USOO7651979B2 (12) United States Patent (10) Patent No.: US 7.651,979 B2 Lippard et al. (45) Date of Patent: *Jan. 26, 2010 (54) COORDINATION COMPLEXES, AND Friedhelm Balkenhohl et al., "Combinatorial Synthesis of Small METHODS FOR PREPARING BY Organic Molecules'. Angew. Chem. Int. Ed, Engl., 35, pp. 2289-2337 COMBINATORIAL METHODS,ASSAYING (1996). AND USING THE SAME Steven F. Bellon et al., “Bending studies of DNA site-specifically modified by cisplatin, trans-diamminedichloroplatinum(II) and cis (75) Inventors: Stephen J. Lippard, Cambridge, MA Pt(NH)(N3-cytosine) C1)” Biophysical Chemistry, vol. 35, pp. (US); Christopher J. Ziegler, Waltham, 179-188 (1990). MA (US) (Continued) (73) Assignee: Massachusetts Institute of Technology, Primary Examiner Jeffrey S. Lundgren Cambridge, MA (US) (74) Attorney, Agent, or Firm—Dana M. Gordon; Foley Hoag LLP (*) Notice: Subject to any disclaimer, the term of this patent is extended or adjusted under 35 (57) ABSTRACT U.S.C. 154(b) by 447 days. This patent is Subject to a terminal dis The present invention relates to novel coordination com claimer. plexes, methods for synthesizing and identifying coordina tion complexes, using combinatorial techniques, and assay (21) Appl. No.: 10/928,929 ing their activity. In certain embodiments, the invention relates to a library comprising a plurality of platinum-con (22) Filed: Aug. 27, 2004 taining coordination complexes represented by the general formula {PtLA}, wherein, independently for each (65) Prior Publication Data occurrence, each L is a non-labile ligand understandard con US 2005/0227290 A1 Oct. 13, 2005 ditions, each n is equal to 1, 2 or 3; each A is a labile ligand under standard conditions; and each Pt is Pt(II) or Pt(IV); Related U.S. Application Data provided that when Pt is Pt(IV), two additional ligands in the trans axial positions of the general formula depicted are (63) Continuation of application No. 09/907,515, filed on present; and at least one of the plurality of platinum-contain Jul. 16, 2001, now Pat. No. 6,806,289. ing coordination complexes is represented by the formula (60) Provisional application No. 60/218,335, filed on Jul. 14, 2000. (51) Int. Cl. C40B 40/8 (2006.01) Y (52) U.S. Cl. ............................. 506/22:506/13:506/21; 514/492; 424/649; 423/22 (58) Field of Classification Search ....................... None See application file for complete search history. (56) References Cited wherein, independently for each occurrence: X represents U.S. PATENT DOCUMENTS halogen or other labile ligand under standard conditions; W 5,359,047 A 10, 1994 Donahue et al. ........... 536,235 represents S, N, or P;Y represents —OR7. —SR7, a halogen 5,625,048 A 4, 1997 Tsien et al. ................ 536,234 or —N(R9)R10; R9 and R10, each independently, represent 5,955,604 A 9, 1999 Tsien et al. ................. 540,222 —H, alkyl, alkenyl, —(CH), R7, or R9 and R10, taken 6,806,289 B1* 10/2004 Lippard et al. .............. 514,492 together with the Natom to which they are attached complete a heterocycle having from 4 to about 8 atoms in the ring structure, all optionally substituted; L represents a non-labile FOREIGN PATENT DOCUMENTS ligand under standard conditions; R7 represents —H, alkyl, WO WO96,30540 10, 1996 aryl, cycloalkyl, cycloalkenyl, heterocycle or polycycle; the ligand V comprises W.Y. and a heterocycle having from 4 to OTHER PUBLICATIONS about 8 atoms in the ring structure, optionally aromatic and optionally substituted; and the symbol Raynaud et al., Clinical Cancer Research 3:2063-2074 (1997).* Trevor G. Appleton et al., “Reactions of Platinum (II) Aqua Com plexes. 2. ' Pt NMR Study of Reactions between the Tetraaquaplatinum (II) Cation and Chloride, Hydrozide, Percholarate, Nitrate, Sulfate, Phosphate, and Acetate'. Inorganic Chemistry, vol. 2, No. 22, pp. 3521-3525 (1984). x Robert W. Armstrong et al., “Multiple-Component Condensation Strategies for Combinatorial Library Synthesis'. Acc., Chem. Res. American Chemical Society, vol. 29, No. 3, pp. 123-131 (1996). represents a single or a double bond. R. Bakhtiar et al., “Pharmacological applications of inorganic com plexes”. General Pharmacology, vol. 32, pp. 525-540 (1999). 2 Claims, 13 Drawing Sheets US 7.651,979 B2 Page 2 OTHER PUBLICATIONS Harold C. Harder et al., “Inhibitory Effects of Anti-Tumor Platinum Compounds on DNA, RNA and Protein Syntheses in Mammalian Erich E. Blatter et al., “Interaction of the Antitumor Agents cis, cis, Cells In Vitro”, Int. J. Cancer, 6, pp. 207-216 (1970). trans-Pt(NH )CL2(OH) and cis, cis, tran Jerry A. Howle et al., “CIS-Dichlorodiammineplatinum (II) Persis Pt(CH3)2CHNHCL2(OH) and Their Reduction Products with tent And Selective Inhibition of Deoxyribonucleic Acid Synthesis. In PM2 DNA”, American Chemical Society, vol. 23, No. 21, pp. 4817 Vivo”. Biochemical Pharmacology, vol. 19, pp. 2757-2762 (1970). 4820 (1984). Elizabeth R. Jamieson et al., “Structure, Recognition, and Processing PD. Braddocket al., “Structure and Activity Relationships of Plati of Cisplatin-DNA Adducts'. American Chemical Society, Chem. num Complexes with Anti-Tumour Activity” Chem.-Biol Interac Rev, vol. 99, No. 9, pp. 2467-2498 (1999). tions, vol. 11, pp. 145-161 (1975). Thomas W. Jones et al., “Cis-Diamminedichloroplatinum (II)-In Gabriel Briceno et al., “A Class of Cobalt Oxide Magnetoresistance duced Acute Renal Failure in the Rat—Correlation of Structural and Materials Discovered with Combinatorial Synthesis'. Science, vol. Functional Alterations”. Laboratory Investigation, vol. 52, No. 4, pp. 270, pp. 273-275 (1995). Matthew T. Burger et al., “Synthetic lonophores. Encoded 363-374 (1985). Combinatorial Libraries of Cyclen-based Receptors for Cu'Co', S. R. Kain et al., “Green Fluorescent Protein as a Reporter of Gene J. Org. Chem., vol. 60, No. 23, pp. 7382-7383 (1999). Expression and Protein Localization'. BioTechniques, vol. 19, No. 4. Kevin Burgess et al., “New Catalysts and Conditions for A C-H pp. 650-655 (1995). Insertion Reaction Identified by High Throughput Catalyst Screen Jana Kaspárková et al., “Effect of Geometric Isomerism in Dinucler ing” Andew. Chem. Int. Ed. Engl, vol. 35. No. 2, pp. 220-222 (1996). Platinum Antitumor Complexes on DNA Interstrand Cross-Link Dominique Burnouf et al., “Spectrum of Cisplatin-induced Muta ing, Biochemistry, vol. 38, No. 34, pp. 10997-11005 (1999). tions. In Escherichia coli'', Proc. Natl. Afad. Sci USA, vol. 84, pp. Miriam B.G. Kloster et al., "Consequences of Nucleic Acid Confor 3758-3762 (1987). mation on the Binding of a Trinuclear Platinum Drug" Biochemistry, Burton et al., “Florescein Dyes Derived From 2-Methylresocinol”.J. vol. 38, No. 45, pp. 14731-14737 (1999). S.C.I., vol. 67, pp. 345-347 (1948). K. W. Lee et al., Cis-dichlorodiammineplatinum(II). Aquation Equi David A. Campbell et al., “A Transition State Analogue Inhibitor libria and Isotopic Exchange of Chloride Ligands with Free Combinatorial Library”. J. Am. Chem. Soc., vol. 117, pp. 5381-5382 Choloride and Tetrachloroplatinate(II), Inorganica Chimica Acta, (1995). vol. 17, pp. 105-110 (1976). Yu Chen et al., “Stereospecific and Kinetic Control over the Gary LeRoy et al., “Requirement of RSF and FACT for Transcription Hydrolysis of a Sterically Hindered Platinum Picoline Anticancer of Chromatin Templates in Vitro”, Science, vol. 282, pp. 1900-1904 Complex”, Chem. Eur: J., vol. 4, pp. 672-676 (1998). (1998). Annalisa Chiocchetti et al., “Green Fluorescent protein as a reporter Shuang Liu et al., “’" Tc-Labeled Small Peptides as Diagnositic of gene expression in transgenic mice'. Biochimica et Biophsica Radiopharmaceuticals'. American Chemical Society, Chemical Acta, vol. 1352, pp. 193-202 (1997). Reviews, vol. 99, No. 9, pp. 2235-2268 (1999). Takashi Chishima et al., "Cancer Invasion and Micrometastasis Visu Colin James Lyne Locket al., "Crystal and Molecular Structures of alized in Live Tissue by Green Fluorescent Protein Expression'. cis- and trans-Dichlorobis (cyclobutylamine-N) platinum (II), Cancer Research, 57, 2042-2047 (1997). PtCl(CH-NH), and some Comments on the Conversion of Cisto Andrew P. Combs et al., “Protein Structure-Based Combinatorial Trans” Inorg. Chem, vol. 20, No. 6, pp. 1817-1823 (1981). Chemistry: Discovery of Non-Peptide Binding Elements to Src SH3 Patrick J. Loehrer, M.D., et al., “Diagnosis and Treatment—Drugs Domain”. J. Am. Chem. Soc., 118 pp. 287-288 (1996). Five Years Later'. Annals of Internal Medicine, vol. 100, No. 5, pp. P. M. Cowley et al., “Applications of Solid-Phase Synthesis to Drug 704-713 (1984). Discovery'. Current Medicinal Chemistry, vol. 4, pp. 211-227 Reinhard Malin et al., “Identification of Technetium-99m Binding (1997). Peptides Using Combinatorial Cellulose-Bound Peptide Libraries'. Andrew B. Cubitt et al., Understanding, improving and using green J. Am. Chem. Soc., vol. 117, No. 47, pp. 11821-11822 (1995). fluorescent proteins:, Techniques TiBS, 20, pp. 448-455 (1995). Jill A. Mello et al., “The mismatch-repair protein hMSH2 binds S. C. Dhara, A Rapid Method for the Synthesis of cis slectively to DNA adducts of the anticancer drug cisplatin”. Chem Pt(NH3)2CL:, Indian Journal of Chemistry, vol. 8, No. 2, pp. istry & Biology, vol. 3, No. 7, pp. 579-589 (1996). 193-194 (1970). D. D. Mosser et al., “Use of a Dicistronic Expression Cassette Encod S.G. Dixit et al., "Combinatorial Chemistry—Principles and Prac ing the Green Fluorescent Protein for the Screening and Selection of tices”,Journal of Scientific & Industrial Research, vol. 57, pp. 173 Cells Expressing Inducible Gene Products'. BioTechniques, vol. 22. 183 (1988). No. 1, pp. 150-161 (1997). David J. Ecker et al., “Combinatorial Drug Discovery: Which Meth Michael C. Needels et al., “Generation and screening of an ods Will Produce the Greatest Value?”, Bio/Technology, vol. 13, pp. oligonucleotide-encoded synthetic peptide library”. Proc. Natl. 351-360 (1995). Acad. Sci., vol. 90. pp. 10700-10704 (1993). H.N.A. Fraval et al., “Increased Sensitivity of UV-Repair-Deficient Human Cells To DNA Bound Platinum Products Which Unlike Michael H.J.